Innovative Cancer Testing Now Available in Japan
Fujita Health University and BostonGene have partnered to enhance access to genomic cancer testing for patients in Japan. This partnership introduces the BostonGene Tumor Portrait™ test at the Fujita Health University Haneda Clinic, marking a significant step in advancing cancer care through innovative testing solutions.
Understanding the Tumor Portrait™ Test
The Tumor Portrait™ test is a cutting-edge genomic profiling tool that is vital for oncologists. It helps by identifying actionable mutations and biomarkers that predict patient responses to various treatments. By integrating results from DNA and RNA sequencing alongside patient clinical data, this test produces a comprehensive report that guides treatment decisions.
Key Features of the Tumor Portrait™ Test
This advanced test showcases the significant drivers behind individual tumors, highlighting genetic mutations and immune interactions. It assists in tailoring personalized treatment strategies based on specific tumor profiles, ultimately improving patient outcomes.
Enhancing Patient Access to Treatments
The availability of the Tumor Portrait™ test at Fujita Health Haneda Clinic provides patients access to not only diagnostic testing but also cutting-edge oncological gene therapies. These therapies leverage genetic analysis to improve diagnosis speed and treatment efficacy, particularly for patients experiencing relapses.
Expert Insights on the Collaboration
Dr. Hideyuki Saya from Fujita Cancer Center expressed enthusiasm about this new testing option. He emphasized the potential for the Tumor Portrait™ test to positively influence both patient care and ongoing cancer research. Similarly, Dr. Tamotsu Sudo noted that this cancer gene panel test could help predict the effectiveness of immune checkpoint inhibitors, helping to select the most appropriate treatments while minimizing unnecessary side effects.
A Commitment to Precision Medicine
Yukimasa Shiotsu, President of BostonGene Japan, highlighted the collaboration's importance in advancing precision medicine. By providing the Tumor Portrait™ test to more cancer patients in Japan, this partnership aims to ensure that patients benefit from tailored therapies that enhance their quality of life.
About Fujita Health University Hospital
Fujita Health University is recognized as one of Japan's prominent universities, featuring a large medical facility equipped with 1,376 beds and conducting around 13,500 surgeries annually. The university hospital is significant as a designated “Area Cancer Medical Treatment Cooperation Base Hospital (High Level).” Its comprehensive treatment plans encompass surgical, radiological, and chemotherapy options, reflecting its commitment to advanced patient care.
About Fujita Health University Haneda Clinic
Recently established, the Fujita Health University Haneda Clinic focuses on cutting-edge medical research, particularly in the fields of cancer genomics and regenerative medicine. Its mission is to leverage modern scientific advancements to provide private healthcare solutions that address complex medical needs.
About BostonGene Corporation
BostonGene is a leader in biotechnology, utilizing advanced computational biology and precision medicine. Founded in 2015, the company uses AI-powered multiomics platforms to decode the molecular profiles of cancer patients. Its efforts aim to improve patient care significantly while accelerating the drug development process.
BostonGene Japan's Vision
BostonGene Japan, a joint venture formed with NEC Corporation and Japan Industrial Partners, is committed to revolutionizing personalized medicine. This collaboration seeks to enhance cancer therapies, ensuring they are personalized and effective for every patient.
Frequently Asked Questions
What is the Tumor Portrait™ test?
The Tumor Portrait™ test is a genomic testing solution that identifies mutations and biomarkers in cancer patients, aiding in personalized treatment plans.
Why is this partnership significant?
This collaboration enhances access to advanced genomic testing in Japan, promoting personalized medicine and improving cancer care.
Who benefits from the Tumor Portrait™ test?
Cancer patients at Fujita Health University Haneda Clinic will benefit from this test, which provides crucial insights for treatment decisions.
What advanced therapies are available at the clinic?
Patients have access to gene therapies and treatment options that utilize genetic analysis for improved diagnosis and personalized care.
How does BostonGene's technology work?
BostonGene employs AI and multiomics platforms to analyze cancer patients' molecular profiles, helping to reveal disease drivers and effective treatment options.
